Founder & CEO at Sentynl Therapeutics, Inc. - , ,
Senior Vice President & General Counsel
Contact Michael Hercz
Sr. Director of Regulatory Affairs and Quality
Contact Eileen Banaga
key accounts specialist
Contact Danielle Overly
Contact Stacey Collins
key account specialist
Contact Demarcus Blake
Quality Assurance Manager
Contact Cindy A.
Jr. Accountant/Coordinator
Contact Colleen Mitchel
Sentynl Therapeutics, a wholly owned subsidiary of Zydus Cadila Pharmaceuticals, is a commercial stage biopharmaceutical company focused on bringing innovative therapies to patients living with rare diseases.